Corbus enrols first patient in Phase II trial of Resunab to treat cystic fibrosis in adults

US-based Corbus Pharmaceuticals Holdings has started patient enrolment in the Phase II clinical trial of its investigational new drug Resunab to treat adult patients with cystic fibrosis (CF).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news